Quels seront les bénéfices à long terme des nouveaux traitements

Newsletter(5(–(janvier(2015(
(
(
Quels(seront(les(bénéfices(à(long(terme(des(nouveaux(traitements(de(l’hépatite(C?(
(
!"#$%&'()*+%'',(-".$/.0%12(34(5+%''%(6&7"$2(8"&'0"+.9:/;;+%&(
!
Commentaire(d’article(
(
Younossi(Z(et(al.(Digestive(&(Liver(Disease(2014(
(
INTRODUCTION(
<=%#(>?@(@@@(@@@(7%(A%'1"..%1(+.B%#$C%1(7/.1(;%(D".7%2(;E*CA/$+$%(3(%1$(&.((%.F%&(D/F%&'(7%(1/.$C(A&G;+H&%I(J%1(
A/$+%.$1( +.B%#$C1( A/'( ;%( =+'&1( 7%( ;E*CA/$+$%( 3( 1"&BB'%.$( A*,1+H&%D%.$( %$( A1,#*";"0+H&%D%.$( K( "&$'%( ;/( D/;/7+%(
*CA/$+H&%2( ;E/1$*C.+%2( ;/( 7CA'%11+".2( ;E/.L+C$C( ".$( 7%1( 'CA%'#&11+".1( 1&'( ;%&'( H&/;+$C( 7%( =+%( %$( ;/( A'"7&#$+=+$C(
+.7+=+7&%;;%I(
!%A&+1( M@>N2(7%(."&=%;;%1( D";C#&;%1( ".$( '%O&( &.%( /&$"'+1/$+".( 7%( D+1%( 1&'( ;%( D/'#*C( 7/.1( ;%( $'/+$%D%.$( 7%(
;E*CA/$+$%( 3I( 3%1( 7%'.+P'%1( A%'D%$$%.$( &.( $/&L( 7%(0&C'+1".(1&AC'+%&'(/&L($'/+$%D%.$1(/.$+(=+'/&L(/.$C'+%&'1(/=%#(
D"+.1(7E%BB%$1(+.7C1+'/G;%1(%$(&.%(7&'C%(A;&1(#"&'$%(7%($'/+$%D%.$I(!%A&+1(;E"G$%.$+".(7%(;/(D+1%(1&'(;%(D/'#*C(7%(#%(
$'/+$%D%.$2(;%&'(A'+L(%$(;%1($,A";"0+%1(7%1(A/$+%.$1(Q($'/+$%'(".$(C$C(/&(#R&'(7%1(7CG/$1I((
(
OBJECTIFS(
JE"GF%#$+B( 7%( #%( $'/=/+;( C$/+$( 7E/./;,1%'(;%(GC.CB+#%(7%(#%1(."&=%/&L($'/+$%D%.$1(1&'(;%1('C1&;$/$1(=+'";"0+H&%12(
#;+.+H&%12(C#"."D+H&%1(%$(1&'(;/(H&/;+$C(7%(=+%(7%1(A/$+%.$1(1%;".(7%&L(/AA'"#*%1(K(
9( J%1( %BB%$1( 7&( $'/+$%D%.$( '/AA"'$C1( A/'( ;%1( A/$+%.$1( %.( D/$+P'%( 7%( H&/;+$C( 7%( =+%( Q( A/'$+'( 7%( ."DG'%&L(
1$/.7/'71( K( 4STTJ2( U-NV2( T<JWEUI( 3%1( 1$/.7/'71( '%A'C1%.$%.$( 7%1( C#*%;;%1( "BB+#+%;;%1( 7EC=/;&/$+".( 7%( ;/(
H&/;+$C(7%(=+%I(
9( J%1(/1A%#$1(C#"."D+H&%1(7&($'/+$%D%.$(7%(;E*CA/$+$%(3(
(
PRINCIPAUX(RESULTATS(
<A'P1(#".$/D+./$+".2(".(%1$+D%(7%(?X(Q(Y@Z(;%('+1H&%(7%(7%=%.+'(A"'$%&'(#*'".+H&%(7&(=+'&1(3I(5/'D+(#%1(A/$+%.$12(
M@(Q(MXZ(=".$(C=";&%'(=%'1(&.%(#+''*"1%(%$(>(Q(XZ(7%1(A/$+%.$1(+.B%#$C1(=".$(7C=%;"AA%'(&.(#/.#%'(7&(B"+%I(<&L([U<2(
;/(A'C=/;%.#%(7&(=+'&1(7%(;E*CA/$+$%(3(%1$(%1$+DC%(%.$'%(X(%$(?(D+;;+".1(7%(1&F%$1I(6.(%1$+D%(;%(."DG'%(7%(A/$+%.$1(
/,/.$( &.( 1$/7%( /=/.#C( 7%( ;/( D/;/7+%( *CA/$+H&%( Q( V@>@@@( %.( M@>X2( #".1CH&%.#%( ;"+.$/+.%( 7%( #".$/D+./$+".( 7%1(
G/G,9G""D%'1(.C1(%.$'%(>\]X(%$(>\VX(^>_I(

!%( A;&12( ;%1( A/$+%.$1( +.B%#$C1( A/'( ;%( =+'&1( 3( ".$( 1"&=%.$( 7%1( D/.+B%1$/$+".1( %L$'/9*CA/$+H&%1( '%1A".1/G;%1( 7E&.%(
+DA"'$/.$%( /;$C'/$+".( 7%( ;/( H&/;+$C( 7%( =+%I( 5/'D+( #%1( B/#$%&'12( ;/( 7CA'%11+".2( ;/( B/$+0&%( %$( ;E/.L+C$C( 1".$( ;%1( A;&1(
+DA"'$/.$1I(
JE/G1%.#%( 7%( $'/+$%D%.$( /&0D%.$%( C=+7%DD%.$( ;%( 'C1%'="+'( 7%( A/$+%.$1( +.B%#$C1( A/'( ;%( `43I( [.%( C$&7%( /.0;"9
1/L"..%( /( D".$'C(H&%(1+(MVX@@@(A/$+%.$1(1".$(/#$&%;;%D%.$(#"DA$/G+;+1C1(A"'$%&'1(7&(`432(;%(."DG'%(A/11%'/+$(
./$&'%;;%D%.$(Q(N?@@@@(%.(M@NXI(<+.1+2(;%(#"a$(7%(1/.$C(%1$(%1$+DC(%.$'%(>Y](%$(NV?(D+;;+".1(7%(;+='%1(%.(M@>@(%$(
A/11%'/+$(7%(M>@(Q(]M?(D+;;+".1(7%(;+='%1(%.(M@>X(^M_I(5"&'('C7&+'%(;%1(D/;/7+%1(*CA/$+H&%1(;+C%1(/&(=+'&1(3(7%(Y@(Z2(+;(
B/&7'/+$($'/+$%'($'"+1(B"+1(A;&1(7%(A/$+%.$1(^7"..C%1(%.(<.0;%$%''%_I((
JE/./;,1%(7%(A;&1+%&'1(C$&7%1(^-bUUb6c2(56Ub)S6c2(cd[)Sbc62(-[Ub6c(%$(`<Jdc3d_(D%.C%(/=%#(;%(U6-6U8[`bS(%$(
A"'$/.$( 1&'( ;/( H&/;+$C( 7%( =+%( '/AA"'$C%( A/'( ;%1( A/$+%.$1( /( A%'D+1( 7%( 7CB+.+'( 7%1( B/#$%&'1( A'C7+#$+B1( 7%( D/&=/+1%(
'CA".1%(/&($'/+$%D%.$(K(%.($"&$(A'%D+%'(;+%&(;/(#+''*"1%(D/+1(/&11+(7%1(/.$C#C7%.$1(7%(7CA'%11+".2(B/$+0&%2(/.L+C$C2(
+.1"D.+%(^7"..C%1(%.(/./;,1%( D&;$+9=/'+C%(7%1(C$&7%1(b6c(>(%$(M_I(!E/+;;%&'12(#%1(C=P.%D%.$1(+.7C1+'/G;%1(C$/+%.$(
%L/#%'GC1(7&'/.$(;%($'/+$%D%.$(A/'(G+$*C'/A+%(AC0,;C%I((
<+.1+2(7%1(1#*CD/1( $*C'/A%&$+H&%1( 1+DA;+B+C1( /=%#( D"+.1( 7E%BB%$1(+.7C1+'/G;%1( ;/+11%'/+%.$( %.$'%="+'( 7%( D%+;;%&'1(
'C1&;$/$1( %.( A/'$+%( %.( '/+1".( 7E&.%( D%+;;%&'%( "G1%'=/.#%( $*C'/A%&$+H&%I( !%1( C$&7%1( 'C#%.$%1( D".$'%.$( H&%(
;E/11"#+/$+".(U6-6U8[`bS(eSb8<`bSbcd(A%'D%$(7E"G$%.+'(&.%(/DC;+"'/$+".(7%(;/(H&/;+$C(7%(=+%(#"DA/'C%(/&(1#*CD/(
$*C'/A%&$+H&%( #"DA"'$/.$( 7%( ;Ebc)dS-dS6cI( 5;&1( 'C#%DD%.$2( ;E/11"#+/$+".( U6-6U8[`bSe( Jd!b5<U`bS( /( DfD%(
D".$'C(&.%(/DC;+"'/$+".(7%1('C1&;$/$1(1&'(;/(H&/;+$C(7%(=+%(7&'/.$(;%($'/+$%D%.$I(3%1(."&=%/&L( $'/+$%D%.$1(7E&.%(
7&'C%( 7%( >M( 1%D/+.%1( 1".$( $'P1( G+%.( $";C'C1( %$( 1E/##"DA/0.%.$( 7E&.%( D%+;;%&'%( "G1%'=/.#%I( !E/&$'%1( 1#*CD/1(
$*C'/A%&$+H&%1( #"DA"'$/.$( 7%( ."&=%;;%1( D";C#&;%1( 1/.1( bc)dS-dS6c( /AA"'$%.$( 7%1( 'C1&;$/$1( 1+D+;/+'%1(
^!<3J<)<U`bS_I(
<./;,1%(C#"."D+H&%(K(0'g#%(/&L(."&=%/&L($'/+$%D%.$12(%.(0&C'+11/.$(A'P1(7%(Y@(Q(\XZ(7%1(A/$+%.$12(;/(A"A&;/$+".(
A"'$%&1%(7&(`43(7%='/+$(7+D+.&%'(7%(YXZ(%$(;/(D"'$/;+$C(A/'(D/;/7+%(7&(B"+%(7%(?@ZIJ%1(C$&7%1(D".$'%.$(H&%(;%(
#"a$(D",%.(7%1(1"+.1(*"'1($'/+$%D%.$1(1AC#+B+H&%1(/.$+(=+'/&L(7E&.(A/$+%.$(/$$%+.$(7E&.%(*CA/$+$%(Q(`43(%1$(7%&L(B"+1(
1&AC'+%&'( Q( #%;&+( 7E&.%( A"A&;/$+".( $CD"+.I( !E&.( A"+.$( 7%( =&%( C#"."D+H&%2( ;%( A"+71( 7%( ;E*CA/$+$%( 3( %1$( +DD%.1%I(
!/.1( &.%( C$&7%( /DC'+#/+.%2( ;%1( #"a$1( 7%1( #"9D"'G+7+$C1( *CA/$+H&%12( *"'1( #+''*"1%( C$/+%.$( %1$+DC1( Q( >?M??(
7";;/'1hA/$+%.$h(/..C%(7%($'/+$%D%.$(#"DA/'C1(/&(MM?XM(7";;/'1(A"&'(;%1(A/$+%.$1(/$$%+.$1(7E&.%(#+''*"1%(#"DA%.1C%I(
d.B+.2( ;%1( #"a$1( /11"#+C1( Q( &.%( +.1&BB+1/.#%( *CA/$"#%;;&;/+'%( $%'D+./;%2( &.( #/'#+."D%( *CA/$"#%;;&;/+'%( %$( &.%(
$'/.1A;/.$/$+".(*CA/$+H&%(C$/+%.$('%1A%#$+=%D%.$(7%(X\\\X(7";;/'12(>>MXN?(7";;/'1(%$(>]X(@@@(7";;/'1hA/$+%.$h/..C%(
7%($'/+$%D%.$I(3"DA$%($%.&(7%(;/(A'C=/;%.#%(7%(;E*CA/$+$%(32(7%1(D/;/7+%1(/11"#+C%1(%$(7&(#"a$(7%(#*/H&%(1$/7%(7%(
;/( D/;/7+%2( ;%( B/'7%/&( C#"."D+H&%( 7&( `43( /&L( [U<( %1$( 7E%.=+'".( \V@@( D+;;+/'71( 7%( 7";;/'1( h( /.I( JEC=/;&/$+".(
C#"."D+H&%(1EC$%.7(G+%.(/&97%;Q(7&(#"&$(7&($'/+$%D%.$(A'"A'%D%.$(7+$I(3%$$%(C=/;&/$+".(7%='/+$(+.#;&'%(;%(#"a$(7&(
1&+=+(7&($'/+$%D%.$2(7%(;/(0%1$+".(7%1(%BB%$1(+.7C1+'/G;%12(7%(;/(A'+1%(%.(#*/'0%(7%1(#"DA;+#/$+".1(;+C%1(Q(;/(D/;/7+%(
/+.1+(H&%(;%1(#"a$1(;+C1(/&L(D/.+B%1$/$+".1(%L$'/9*CA/$+H&%1I(b;(.%(B/&$(A/1(.".(A;&1("&G;+%'(;%1(#"a$1(+.7+'%#$1(A"&'(;/(
1"#+C$CI(3E%1$(1"&=%.$(=%'1(;Eg0%(7%(]@(%$(X@(/.1(H&E%1$(7C#"&=%'$%(;E+.B%#$+".(=+'/;%(32(Q(&.%(CA"H&%("i(;/(A%'1"..%(
%1$(;/(A;&1(A'"7&#$+=%(1"#+/;%D%.$I([.(A"'$%&'(7&(=+'&1(3( /(&.(/G1%.$C+1D%(1+0.+B+#/$+=%D%.$(1&AC'+%&'(Q(&.(1&F%$(
1/.1(+.B%#$+".(=+'/;%(^>IX(B"+1(1&AC'+%&'_I(!/.1(&.%(C$&7%('C#%.$%2(;E/11"#+/$+".(U6-6U8[`bS(e(Jd!b5<U`bS(/(A%'D+1(
7%( #".1$/$%'( &.%( /DC;+"'/$+".( %.( $%'D%1( 7%( A'"7&#$+=+$C( +.7+=+7&%;;%I( U+( ".( %.=+1/0%( &.( $'/+$%D%.$2( ;/( A'+1%( %.(
#*/'0%($*C'/A%&$+H&%(7"+$($%.+'(#"DA$%(7&(#"a$(0;"G/;(7&(D".+$"'+.0(7%1(A/$+%.$1(K(1&+=+(#;+.+H&%2(/./;,1%(G+";"0+H&%2(
#"&$(7%(A'+1%(%.(#*/'0%(7%1(%BB%$1(+.7C1+'/G;%1(^7CA'%11+".2('/1*(#&$/.C2(/.CD+%2(;%&#"AC.+%9$*'"DG"AC.+%j_(<+.1+(
;%(#"a$(7%1($'+$*C'/A+%1(#"DA"'$/.$(7%1(/.$+9A'"$C/1%1(7%(>P'%(0C.C'/$+".(C$/+$(;/'0%D%.$(/&0D%.$C(A/'(;/(0%1$+".(
7%1(%BB%$1(+.7C1+'/G;%1(%$(7&(D".+$"'+.0(=+'/;I(
J%1(/./;,1%1(C#"."D+H&%1(7%1(."&=%/&L($'/+$%D%.$1(1%(A"1+$+"..%.$(%.(B/=%&'(7%(1#*CD/1($*C'/A%&$+H&%1(1+DA;%12(
1/.1(bc)dS-dS6c(%$(1/.1(Sb8<`bSbcd2(7%(7&'C%(#"&'$%(%$(7E%BB+#/#+$C('%D/'H&/G;%(H&/1+D%.$(1/.1(%BB%$(+.7C1+'/G;%I(
!%1(C$&7%1(1&'(;%1(7"..C%1(7%(;/(='/+%(=+%(1".$(%.(#"&'1I((
3"DA/'C( Q( 7E/&$'%1( D/;/7+%1( #*'".+H&%1( ^7+/GP$%( 7%( $,A%( M2( A";,/'$*'+$%( '*&D/$"k7%2( +.B%#$+".( Q( `b42( #/.#%'(
G'".#*"9A&;D"./+'%("&(1#;C'"1%(%.(A;/H&%_2(1+(;%(#"a$(+.+$+/;(7&($'/+$%D%.$(/.$+=+'/;(1%DG;%($'P1(C;%=C2(Q(D",%.(%$(
;".0($%'D%2(0'g#%(Q(;/(0&C'+1".(%$(Q(;/('%A'+1%(7E&.%(/#$+=+$C(A'"B%11+"..%;;%2(0'g#%(Q(;/(7+1A/'+$+".(7%(D/.+B%1$/$+".1(
1,DA$"D/$+H&%12(7C;C$P'%1(/AA'C#+C%1(A/'(;%1(7+BBC'%.$1(1#"'%1(7%(H&/;+$C(7%(=+%2(#%(1&'#"a$(1%DG;%(A"&="+'(7%=%.+'(
'%;/$+B(%$(1E%BB/#%'(/&(B+;(7&($%DA1I(

(
CONCLUSION(
JE*CA/$+$%(3(#*'".+H&%(/(7%1(#".1CH&%.#%1(D&;$+9B/#$"'+%;;%1(7C;C$P'%1(A"&'(;%1(A/$+%.$1(H&E+;(1E/0+11%(7%(;/(D/;/7+%(
*CA/$+H&%2(7%1(D/.+B%1$/$+".1(%L$'/9*CA/$+H&%1(%$(7%(;/(H&/;+$C(7%(=+%I(J%1(."&=%/&L($'/+$%D%.$1(1/.1(bc)dS-dS6c(
%$(1/.1( Sb8<`bSbcd( /DC;+"'%.$(;%1('C1&;$/$1(7%( B/O".( 1A%#$/#&;/+'%I( JE/DC;+"'/$+".("G$%.&%( A%'D%$(7%( .&/.#%'( %$(
'%;/$+=+1%'(;%(A"+71(B+./.#+%'(7&(#"a$(7&($'/+$%D%.$(0'g#%(Q(&.(+DA/#$(A"1+$+B(1&'(;%(A/$+%.$2(1/(B/D+;;%(%$(;/(1"#+C$CI(b;(
1%'/+$(+DA"'$/.$(7%(D+%&L(7"#&D%.$%'(;/('CA%'#&11+".(7%(;E+DA/#$(7E&.%(+.B%#$+".(Q(=+'&1(3(1&'(;/(A'"7&#$+=+$C(
+.7+=+7&%;;%(%$(;%1(#".1CH&%.#%1(A"&'(;%(A/$+%.$(A"'$%&'(7&(=+'&1(3I(J%1('C#%.$%1(7"..C%1(C#"."D+H&%1(A"'$/.$(1&'(
#%1( ."&=%/&L( $'/+$%D%.$1( D".$'%.$( ;%&'( %BB+#/#+$C( %$( &.( 'C%;( GC.CB+#%( C#"."D+H&%( A"&'( ;/( 1"#+C$CI( JE/AA'"#*%(
%L#;&1+=%D%.$( #"DA$/G;%( 7&( #"a$( 7&( $'/+$%D%.$( %1$( +.1&BB+1/.$%( %$( F&1$+B+%( 7E&.%( /AA'"#*%( A;&1( 0;"G/;%( %.( 1/.$C(
A&G;+H&%I(
(
REFERENCES(
>9l/;%1/m(nI(-'/.#+1(o2(3%7%".(<(%$(/;I(3&''%.$(/.7($*%(B&$&'%(7+1%/1%(A'"0'%11+".("B($*%(#*'".+#(43`(A"A&;/$+".(+.(
$*%([.+$%7(U$/$%1I(5J6U(6cd(M@>N(K(Y(K(%VN\X\(
M95/$'&.+( 82( c";$%( dI( <( A'"F%#$+".( "B( $*%( *%/;$*#/'%( /.7( %#"."D+#( G&'7%.( +.( $*%( [o( S<c!( #"'A"'/$+".( '%A"'$(
4%A/$+$+1( 3I( 5'%A/'%7( B"'( $*%( 4%A/$+$+1( 3( )'&1$( K( M@>N( 6G$/+.%7( B'"D( $*%( p"';7( p+7%( p%G( /$( S<c!( d&'"A%( K(
*$$AKhhpppI'/.7I"'0h'/.7%&'"A%(^/##%11%7(M\I@?I>]_(
N94";DG%'0(U!2(UA'/7;+.0(5S2(n""'D/.(<32(%$(/;I(4%A/$+$+1(3(+.($*%([.+$%7(U$/$%12(c(d.0(:(n%7(M@>Nq(NVY(K(>YX\9V>I(
!
!
!
!
!
!
!
!
!
!
!
!
!
Newsletter réalisée grâce au soutien institutionnel du laboratoire Bristol-Myers Squibb!